Transposon said its oral small molecule TPN-101 has been selected for testing as part of the HEALEY ALS platform trial.

After auditing her daily schedule to improve productivity, columnist Dagmar Munn realizes that her time is actually well spent.

Living in the moment takes a lot of practice. ALS makes the past a place to visit for short periods of time, but dwelling on the future for too long can create an unbearable fear. That’s why it’s so ...

Genetic mutations in many forms of ALS lead to early problems with the transport and function of mitochondria, a study found.

Antidepressants that inhibit REM sleep are associated with prolonged survival in people with amyotrophic lateral sclerosis, a ...

Everyone has spaces that bring peace, and life with ALS doesn't change that, writes columnist Juliet Taylor, who shares her ...

On June 2, supporters across the U.S. will recognize the legacy of legendary baseball player Lou Gehrig and his impact on ALS ...

Columnist Kristin Neva, while enjoying an unusually busy weekend, reflects on how finding balance is crucial in her life as an ALS caregiver.

The ALS Network is supporting research using electronic health records to identify existing drugs for repurposing to slow ALS progression.